Journal profile · Multiple
Cardio-Oncology
ISSN 2057-3804 · Springer Nature · United Kingdom
Cardio-Oncology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.4 (journal website); fully open access; APC about USD 2,890; median 108 days to acceptance (104 articles, last 24 months); 126 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Cardio-Oncology is published by Springer Nature and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Chemotherapy-induced cardiotoxicity and mitigation, Lung Cancer Research Studies and Cancer Treatment and Pharmacology, together about 51.5% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine and Oncology. (generated from OpenAlex topic counts and CAS ranking data)
The mission of Cardio-Oncology is to promote the science, technology, practice, and betterment of the public health of the emerging field of cardio-oncology. We are an international, open access journal that strives to publish original, important, valid, peer-reviewed articles on a diverse range of medical topics related to cardiovascular effects of cancer treatments. The journal welcomes submissions related to the pathophysiology, prevention, diagnosis, and treatment of the effects of cancer therapies, from basic mechanistic studies, to translational, preclinical and clinical research, including clinical trials, outcomes studies, case reports, and imaging techniques. Topical areas include, but are not limited to: Preclinical and clinical mechanisms of the cardiotoxicity of anticancer drugs; Biomarkers and the susceptibility of cancer patients to cardiovascular injury; Cancer treatment for patients with a cardiovascular history; Monitoring and detection of patients at risk of cardiotoxicity; Prevention and treatment strategies, such as dose changes for chemotherapy; Cardiovascular care for cancer survivors; Quality, safety, human factors and reliability of cancer care; Health systems design and strengthening. Cardio-Oncology is the premier journal devoted exclusively to this emerging specialty, providing an international forum for elevating the quality of medical care, disease prevention, and research via state-of-the-art reviews, filling a critical gap in the science and clinical practice of this important field. The journal serves to inform readers about the various aspects of cardio-oncology medicine and public health, including cultural, sociopolitical, ethical, legal, environmental, economic, structural, and historical issues. We are committed to producing a high impact and credible publication that is timely and enjoyable to read.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Joseph CarverPublisher website
Editorial board by country: 6 in mainland China (about 5%); most named United States 74, Italy 11, Mainland China 6, Netherlands 6, United Kingdom 5 (131 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Chemotherapy-induced cardiotoxicity and mitigationMedicine36.8%
- Lung Cancer Research StudiesMedicine8.9%
- Cancer Treatment and PharmacologyMedicine5.8%
- Cardiac Imaging and DiagnosticsMedicine5.4%
- Cardiovascular Function and Risk FactorsMedicine4.2%
- Cancer Immunotherapy and BiomarkersMedicine4%
- Cardiac tumors and thrombiMedicine3.3%
- Cancer-related cognitive impairment studiesMedicine3.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbasePublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 3.4Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.3Publisher website ·
- CiteScore 2026-06
- 3.8LetPub ·
- SJR 2026-06
- 0.85LetPub ·
- SNIP 2026-06
- 0.95LetPub ·
- h-index
- 33OpenAlex ·
- i10-index
- 131OpenAlex ·
- 2-year mean citedness
- 2.26OpenAlex ·
- Self-citation rate
- 5.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 115LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 396,600Publisher website ·
Articles by year OpenAlex count · 603 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 150 | 150 | 27 |
| 2025 | 126 | 126 | 270 |
| 2024 | 93 | 93 | 537 |
| 2023 | 47 | 47 | 490 |
| 2022 | 23 | 23 | 277 |
| 2021 | 40 | 40 | 747 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
108 daysMedian, submission to acceptance · P25–P75 76 days – 165 days
- Acceptance to online
- median 19 days (104 articles)
- Submission to online
- median 138 days
- Sample
- 104 articles with submission and acceptance dates (303 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 7 weeksLetPub ·
- Submission to first decision
- 12 daysPublisher website ·
- Submission to publication (journal-reported)
- about 7 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,490 / USD 2,890 / GBP 2,090 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,790 / EUR 2,390 / GBP 1,990 | — | — | |
| LetPub | GBP 1,890 / USD 2,690 / EUR 2,290 | Yes | — | |
| Publisher website | GBP 2,090 / USD 2,890 / EUR 2,490 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted5
- case reportResearch Review Case Report Correspondence MethodologyLength not stated
- correspondenceResearch Review Case Report Correspondence MethodologyLength not stated
- methodologyResearch Review Case Report Correspondence MethodologyLength not stated
- researchResearch Review Case Report Correspondence MethodologyLength not stated
- reviewResearch Review Case Report Correspondence MethodologyLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Data sharing strongly encouraged or required. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access under CC BY-NC-ND or CC BY licence. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Cardio-Oncology articles are published open access under a CC BY-NC-ND (Creative Commons Attribution Non-Com…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Editorial policies are on the BioMed Central website. Model summary
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2057-3804
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Cardio-Oncology
What CAS zone is Cardio-Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cardio-Oncology is in Zone 3 of Medicine, and in Zone 4 of the minor category Cardiac & Cardiovascular Systems / Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cardio-Oncology?
The journal's website gives an impact factor of 3.4 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 3.8, h-index 33.
How long does peer review take at Cardio-Oncology?
Based on the dates recorded on 104 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 108 days (interquartile range 76–165 days); authors report an average review time of about 7 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Cardio-Oncology based?
Of the 131 board members whose country the journal's board page names, 6 (about 5%) are in mainland China; the countries named most often are United States (74), Italy (11) and Mainland China (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Cardio-Oncology?
According to LetPub and DOAJ records, Cardio-Oncology is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Embase; that list has not been checked against each database.
Is Cardio-Oncology open access, and what is the APC?
Cardio-Oncology is a fully open-access journal. APC about USD 2,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .